Cargando…

Long term outcome and side effects in patients receiving low-dose I125 brachytherapy: a retrospective analysis

OBJECTIVES: To retrospectively evaluate the disease free survival (DFS), disease specific survival (DSS),overall survival (OS) and side effects in patients who received low-dose rate (LDR) brachytherapy with I125 stranded seeds. MATERIALS AND METHODS: Between july 2003 and august 2012, 274 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Logghe, Pieter, Verlinde, Rolf, Bouttens, Frank, den Broecke, Caroline Van, Deman, Nathalie, Verboven, Koen, Maes, Dirk, Merckx, Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066886/ https://www.ncbi.nlm.nih.gov/pubmed/27532118 http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0542

Ejemplares similares

Iodine-125 brachytherapy for brain tumours - a review
por: Schwarz, Silke B, et al.
Publicado: (2012)

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model
por: Brun, Thomas, et al.
Publicado: (2018)

CT-guided (125)I brachytherapy for recurrent ovarian cancer
por: Liu, Ping, et al.
Publicado: (2017)

Treatment planning considerations for (125)I eye plaque brachytherapy
por: Miguel, David, et al.
Publicado: (2019)

A Robust Oxygen Microbubble Radiosensitizer for Iodine‐125 Brachytherapy
por: Peng, Sheng, et al.
Publicado: (2021)

Histopathology of Intraocular Medulloepithelioma following Iodine-125 Plaque Brachytherapy
por: Mohan, Sukriti, et al.
Publicado: (2022)

Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma
por: Berkowitz, Sean T., et al.
Publicado: (2022)

Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
por: Wang, Congxiao, et al.
Publicado: (2022)

Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
por: Jiang, Qin, et al.
Publicado: (2021)

CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma
por: Yan, Huzheng, et al.
Publicado: (2017)

Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas
por: Ghassemi, Fariba, et al.
Publicado: (2020)

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
por: Fang, Rui, et al.
Publicado: (2021)

Modification of Source Strength in Low-Dose-Rate Lung Brachytherapy with (125)I and (103)Pd Seeds
por: Rezaei, H., et al.
Publicado: (2017)

Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
por: Okamoto, Keisei
Publicado: (2021)

Quality of life in patients who underwent (125)I brachytherapy, (125)I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer
por: Nakai, Yasushi, et al.
Publicado: (2019)

A machine-learning approach based on 409 treatments to predict optimal number of iodine-125 seeds in low-dose-rate prostate brachytherapy
por: Boussion, Nicolas, et al.
Publicado: (2021)

Salvage low-dose-rate (125)I partial prostate brachytherapy after dose-escalated external beam radiotherapy
por: Chang, Lynn, et al.
Publicado: (2014)

Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
por: Ruge, Maximilian I, et al.
Publicado: (2012)

Bioevaluation of (125)I Ocu-Prosta seeds for application in prostate cancer brachytherapy
por: Mukherjee, Archana, et al.
Publicado: (2014)

Re-implantation after insufficient primary 125-i permanent prostate brachytherapy
por: Putora, Paul Martin, et al.
Publicado: (2013)

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
por: Harada, Kosaku, et al.
Publicado: (2012)

Treasure of the Past IX: Exposure Standardization of Iodine-125 Seeds Used for Brachytherapy
por: Loftus, T. P.
Publicado: (2001)

Palliative treatment of pelvic bone tumors using radioiodine ((125)I) brachytherapy
por: Wang, Chongren, et al.
Publicado: (2016)

Dosimetric parameters of three new solid core I‐125 brachytherapy sources
por: Solberg, Timothy D., et al.
Publicado: (2002)

Value of CT-MRI fusion in iodine-125 brachytherapy for high-grade glioma
por: Gao, Yang, et al.
Publicado: (2017)

Late seed migration after prostate brachytherapy with Iod-125 permanent implants
por: Maletzki, Philipp, et al.
Publicado: (2018)

Evaluation of therapeutic effects of (125)I particles brachytherapy for recurrent bladder cancer
por: Zhou, Yu-Ming, et al.
Publicado: (2018)

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
por: Du, E, et al.
Publicado: (2017)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk Patients
por: Lyons, Lance J, et al.
Publicado: (2019)

I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma
por: Gao, Fu-Lei, et al.
Publicado: (2022)

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023)

Intracranial Ependymoma: Long-Term Results in a Series of 21 Patients Treated with Stereotactic (125)Iodine Brachytherapy
por: El Majdoub, Faycal, et al.
Publicado: (2012)

Measurement of the strength of iodine-125 seed moving at unknown speed during implantation in brachytherapy
por: Tanaka, Kenichi, et al.
Publicado: (2014)

Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
por: Njomnang Soh, Patrice, et al.
Publicado: (2013)

An in vitro verification of strength estimation for moving an (125)I source during implantation in brachytherapy
por: Tanaka, Kenichi, et al.
Publicado: (2018)

Clinicopathologic Analysis of Oral Squamous Cell Carcinoma After (125)I Interstitial Brachytherapy
por: Jie, Wei-ping, et al.
Publicado: (2018)

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer
por: Onishi, Kenta, et al.
Publicado: (2018)

Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
por: Wu, Chunrong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7h9vom11c3rte8a25au6bidkde